MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$1,920,049
Unit: Dollar
Positive Cash Flow Breakdown
Accounts payable, accrued liabil...
Accounts receivable
Non-cash stock-based compensatio...
Others
Negative Cash Flow Breakdown
Deferred revenue
Operating lease liability
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-2,314,139
-2,586,258
-2,802,279
-3,050,373
Non-cash stock-based compensation
176,767
407,761
180,563
157,692
Depreciation and amortization
5,020
4,260
4,555
5,303
Gain on disposal of property and equipment
-
-
0
-
Change in carrying amount of right-of-use asset
41,703
40,552
39,248
41,701
Accounts receivable
-245,100
110,501
-
-
Prepaid expenses and other assets
-65,903
368,103
-173,883
-369,325
Accounts payable, accrued liabilities and other liabilities
336,033
-735,179
582,390
163,331
Deferred revenue
-428,276
58,116
-151,739
521,899
Operating lease liability
-48,160
-46,262
-43,418
-46,674
Net cash used in operating activities
-1,920,049
-3,470,213
-2,016,797
-1,703,197
Proceeds from sale of property and equipment
-
-
0
-
Purchases of property and equipment
0
10,825
0
2,899
Net cash used in investing activities
0
-10,825
0
-2,899
Proceeds from issuance of equity under sepa
-
-
244,018
-
Net cash provided by financing activities
-
-
244,018
-
Effect of exchange rate changes on cash and cash equivalents
6,555
3,976
16,644
9,071
Net change in cash and cash equivalents
-1,913,494
-3,477,062
-1,756,135
-1,697,025
Cash and cash equivalents, beginning of period
27,329,415
30,806,477
32,562,612
40,359,738
Cash and cash equivalents, end of period
25,415,921
27,329,415
30,806,477
32,562,612
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Effect of exchange rate
changes on cash and cash...
$6,555
(165.33%↑ Y/Y)
Net change in cash
and cash...
-$1,913,494
(68.63%↑ Y/Y)
Canceled cashflow
$6,555
Accounts payable,
accrued liabilities and...
$336,033
(217.56%↑ Y/Y)
Accounts receivable
-$245,100
(-282.10%↓ Y/Y)
Non-cash stock-based
compensation
$176,767
(-63.99%↓ Y/Y)
Prepaid expenses and
other assets
-$65,903
(-598.96%↓ Y/Y)
Change in carrying
amount of right-of-use...
$41,703
(-55.03%↓ Y/Y)
Depreciation and
amortization
$5,020
(-50.98%↓ Y/Y)
Net cash used in
operating activities
-$1,920,049
(68.47%↑ Y/Y)
Canceled cashflow
$870,526
Net loss
-$2,314,139
(62.34%↑ Y/Y)
Deferred revenue
-$428,276
Operating lease liability
-$48,160
(54.10%↑ Y/Y)
Buy us a coffee
MEDICINOVA INC (MNOV)
MEDICINOVA INC (MNOV)